Koninklijke Philips N.V. (PHG)
After hours:
| Previous close | 21.53 |
| Open | 20.91 |
| Bid | 20.69 x 1200 |
| Ask | 21.79 x 1000 |
| Day's range | 20.80 - 21.25 |
| 52-week range | 20.20 - 48.72 |
| Volume | |
| Avg. volume | 2,048,341 |
| Market cap | 18.665B |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | 37.91 |
| EPS (TTM) | 0.56 |
| Earnings date | N/A |
| Forward dividend & yield | 0.91 (4.30%) |
| Ex-dividend date | 12 May 2022 |
| 1y target est | 45.07 |
- Business Wire
Philips Signs Health Care Sector Pledge to Reduce Emissions as part of Department of Health and Human Services, White House Initiative
CAMBRIDGE, Mass., July 01, 2022--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has joined an initiative created by the Department of Health and Human Services (HHS), in partnership with the White House, to address climate action through the reduction of greenhouse gas emissions. Earlier this week at the White House, Philips along with other health sector organizations and administration leaders, participated in a roundtable discussion abo
- GlobeNewswire
Philips incorporates Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to advance early lung cancer diagnosis
Lung Cancer Orchestrator June 30, 2022Solution adds proteomic analysis of blood-based biomarkers to Philips Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis and treatment Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has teamed up with Biodesix, Inc. (Colorado, U.S.) (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, to incorporate th
- GlobeNewswire
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
Dreamstation 1 device June 28, 2022 Testing in accordance with ISO 18562 and ISO 10993 standards conducted by five certified, independent testing laboratories in the US and Europe Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG; AEX: PHIA) subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane (PE-PUR) sound abatement foam in specific CPAP, BiPAP and mech
